BR112013010738A2 - composto, composição farmacêutica, e, método para tratar uma infecção viral - Google Patents
composto, composição farmacêutica, e, método para tratar uma infecção viralInfo
- Publication number
- BR112013010738A2 BR112013010738A2 BR112013010738A BR112013010738A BR112013010738A2 BR 112013010738 A2 BR112013010738 A2 BR 112013010738A2 BR 112013010738 A BR112013010738 A BR 112013010738A BR 112013010738 A BR112013010738 A BR 112013010738A BR 112013010738 A2 BR112013010738 A2 BR 112013010738A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- compound
- pharmaceutical composition
- viral infection
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40893810P | 2010-11-01 | 2010-11-01 | |
| US61/408938 | 2010-11-01 | ||
| PCT/US2011/058009 WO2012061190A1 (en) | 2010-11-01 | 2011-10-27 | Alkylsulfinyl-substituted thiazolide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013010738A2 true BR112013010738A2 (pt) | 2016-07-12 |
| BR112013010738B1 BR112013010738B1 (pt) | 2020-03-17 |
Family
ID=45997374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013010738-3A BR112013010738B1 (pt) | 2010-11-01 | 2011-10-27 | Composto de alquilsulfinil tiazolida |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8772502B2 (pt) |
| EP (1) | EP2635124A4 (pt) |
| JP (1) | JP5837936B2 (pt) |
| CN (1) | CN103269593A (pt) |
| AR (1) | AR087725A1 (pt) |
| AU (1) | AU2011323682B2 (pt) |
| BR (1) | BR112013010738B1 (pt) |
| MX (1) | MX2013004724A (pt) |
| NZ (1) | NZ611410A (pt) |
| RU (1) | RU2605745C2 (pt) |
| WO (1) | WO2012061190A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103159697A (zh) * | 2013-04-10 | 2013-06-19 | 安徽中升药业有限公司 | 硝唑尼特的制备方法 |
| US10131643B2 (en) | 2013-07-04 | 2018-11-20 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | Tizoxanide carbamate and pharmaceutical use thereof |
| KR20170081228A (ko) * | 2014-11-11 | 2017-07-11 | 로마크 레버러토리즈, 엘.씨. | 티족사나이드, 그의 유사체 또는 염의 전구 약물을 이용한 치료 조성물 및 방법 |
| KR102136803B1 (ko) | 2016-03-31 | 2020-07-22 | 로마크 레버러토리즈, 엘.씨. | 바이러스 감염을 치료하기 위한 티아졸리드 화합물 |
| AR108175A1 (es) * | 2016-04-06 | 2018-07-25 | Innovative Molecules Gmbh | Compuestos antivíricos de tiazol acetamida |
| ES2935185T3 (es) | 2016-04-11 | 2023-03-02 | Genfit | Métodos para el tratamiento de enfermedades fibróticas |
| WO2018195035A1 (en) | 2017-04-18 | 2018-10-25 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase a3 |
| CN107556201B (zh) * | 2017-09-08 | 2020-10-27 | 山西智创药研科技有限公司 | 一种制备间氨基苯酚的工艺方法 |
| CN107522595A (zh) * | 2017-09-08 | 2017-12-29 | 山西新元太新材料科技发展有限公司 | 一种制备间苯二酚的工艺方法 |
| CA3077397A1 (en) * | 2017-10-05 | 2019-04-11 | Innovative Molecules Gmbh | Enantiomers of substituted thiazoles as antiviral compounds |
| CN112480104A (zh) * | 2019-09-11 | 2021-03-12 | 北京美倍他药物研究有限公司 | 硝唑尼特衍生物及其医药用途 |
| FR3110164A1 (fr) * | 2020-05-15 | 2021-11-19 | Phv Pharma | Procédé de préparation du nitazoxanide et de ses dérivés et utilisation pour la prévention ou le traitement d’états pathologiques dus à l’infection par des virus du type coronavirus, et plus particulièrement du type SARS-CoV-2 |
| US20230303504A1 (en) | 2020-07-20 | 2023-09-28 | Romark Laboratories, L.C. | Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine |
| EP4199923A1 (en) | 2020-08-24 | 2023-06-28 | Romark Laboratories, L.C. | Use of thiazolides against coronaviruses |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169846A (en) | 1989-10-12 | 1992-12-08 | Crooks Michael J | Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators |
| US5578621A (en) | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
| US6040321A (en) * | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| DE10129714A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| WO2008123469A1 (ja) * | 2007-03-30 | 2008-10-16 | Japan Tobacco Inc. | ６員環アミド化合物およびその用途 |
| AU2008299781B2 (en) * | 2007-08-03 | 2013-11-14 | Romark Laboratories L.C. | Alkylsulfonyl-substituted thiazolide compounds |
| CN108042535A (zh) * | 2009-06-26 | 2018-05-18 | 罗马克实验室有限公司 | 用于治疗流感的化合物和方法 |
-
2011
- 2011-10-27 CN CN2011800626842A patent/CN103269593A/zh active Pending
- 2011-10-27 WO PCT/US2011/058009 patent/WO2012061190A1/en active Application Filing
- 2011-10-27 JP JP2013536808A patent/JP5837936B2/ja not_active Expired - Fee Related
- 2011-10-27 NZ NZ611410A patent/NZ611410A/en not_active IP Right Cessation
- 2011-10-27 EP EP11838562.4A patent/EP2635124A4/en not_active Withdrawn
- 2011-10-27 RU RU2013123401/04A patent/RU2605745C2/ru active
- 2011-10-27 MX MX2013004724A patent/MX2013004724A/es active IP Right Grant
- 2011-10-27 BR BR112013010738-3A patent/BR112013010738B1/pt not_active IP Right Cessation
- 2011-10-27 AU AU2011323682A patent/AU2011323682B2/en not_active Ceased
- 2011-10-28 US US13/284,242 patent/US8772502B2/en not_active Expired - Fee Related
- 2011-10-28 AR ARP110104017A patent/AR087725A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120108591A1 (en) | 2012-05-03 |
| RU2013123401A (ru) | 2014-12-10 |
| NZ611410A (en) | 2016-02-26 |
| JP2013544806A (ja) | 2013-12-19 |
| MX2013004724A (es) | 2013-08-29 |
| BR112013010738B1 (pt) | 2020-03-17 |
| AU2011323682A1 (en) | 2013-06-20 |
| JP5837936B2 (ja) | 2015-12-24 |
| AU2011323682B2 (en) | 2016-06-23 |
| AR087725A1 (es) | 2014-04-16 |
| EP2635124A1 (en) | 2013-09-11 |
| US8772502B2 (en) | 2014-07-08 |
| WO2012061190A1 (en) | 2012-05-10 |
| RU2605745C2 (ru) | 2016-12-27 |
| CN103269593A (zh) | 2013-08-28 |
| EP2635124A4 (en) | 2014-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013010738A2 (pt) | composto, composição farmacêutica, e, método para tratar uma infecção viral | |
| BR112015001098A2 (pt) | composto, composição farmacêutica e método para o tratamento de uma condição de doença. | |
| BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
| BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
| BR112014004181A2 (pt) | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia | |
| BR112013026341A2 (pt) | composto, composição farmacêutica, e, método para tratar, prevenir e/ou atrasar o início de uma doença ou patologia | |
| BR112014008126A2 (pt) | composto, método para o tratamento, composição farmacêutica, utilização de um composto e invenção | |
| BR112013015010A2 (pt) | produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112014010197A2 (pt) | composto, composição farmacêutica, método de tratamento de um distúrbio | |
| BR112014015042A2 (pt) | composição farmacêutica, e, método para obter uma composição radiofarmacêutica | |
| PL2672966T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| BRPI0814300A2 (pt) | Composto, composição farmacêutica, e, método para tratar uma infecção viral | |
| BR112014007645A2 (pt) | composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica | |
| PL2729151T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
| BR112014007203A2 (pt) | composto, composição farmacêutica, método de tratamento, utilização de um composto, conjunto e invenção | |
| BR112012026570A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de um indíviduo e produto combinado | |
| BR112014009950A2 (pt) | composto dissubstituído, compostos e composição farmacêutica | |
| BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
| BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BR112013031712A2 (pt) | composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença. | |
| BR112014031899A8 (pt) | composto, composição farmacêutica, e, método para tratamento de um distúrbio | |
| BR112013015085A2 (pt) | composição farmacêutica, método para preparar uma composição, e, uso de composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/10/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2694 DE 23-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |